Key Takeaways
- • Inflexion has acquired Primed Group, a German manufacturer of single-use medical consumables and sterilization services, from Paragon Partners for approximately €300 million, marking the firm's sixth platform acquisition via Buyout Fund VI.
- • The deal strengthens Inflexion's healthcare footprint in the DACH region (Germany, Austria, Switzerland) and expands its exposure to essential medical products and sterilization infrastructure, including the HA2 sterilization platform.
- • Healthcare sector leaders Wolfgang Suessle and Justin Barnes have joined Primed's Board of Directors as part of the transaction, signaling operational continuity and sector expertise in the acquired business.
- • The acquisition represents continued institutional capital deployment in European mid-market healthcare assets, where recurring-revenue sterilization services and consumables offer defensive characteristics aligned with essential medical demand.
Summary
Inflexion, a European mid-market private equity firm, has completed the acquisition of Primed Group, a German-based provider of single-use medical consumables and sterilization services, from Paragon Partners. The transaction, announced on July 14, 2026, carries an enterprise value of just under €300 million and is being funded through Inflexion's Buyout Fund VI.
Primed specializes in the manufacture and distribution of high-quality medical consumables and operates HA2, a large-scale medical sterilization platform that serves customers across the DACH region. The asset provides exposure to essential healthcare infrastructure and recurring-revenue sterilization services, which benefit from structural demand tailwinds in medical device manufacturing and hospital operations.
The acquisition marks Inflexion's sixth platform investment from Buyout Fund VI and represents a deliberate geographic and sectoral deepening within the DACH healthcare market. The firm has positioned the business for operational growth by appointing healthcare leaders Wolfgang Suessle and Justin Barnes to Primed's Board of Directors, establishing institutional governance and operational oversight alongside existing management.
The transaction underscores sustained institutional appetite for mid-market healthcare assets in continental Europe, particularly in subsectors characterized by essential-use consumables and mission-critical sterilization infrastructure. Such assets typically generate stable cash flows underpinned by non-discretionary demand from hospitals and medical device manufacturers, making them defensible investment themes within healthcare-focused private equity strategies.
Primed specializes in the manufacture and distribution of high-quality medical consumables and operates HA2, a large-scale medical sterilization platform that serves customers across the DACH region. The asset provides exposure to essential healthcare infrastructure and recurring-revenue sterilization services, which benefit from structural demand tailwinds in medical device manufacturing and hospital operations.
The acquisition marks Inflexion's sixth platform investment from Buyout Fund VI and represents a deliberate geographic and sectoral deepening within the DACH healthcare market. The firm has positioned the business for operational growth by appointing healthcare leaders Wolfgang Suessle and Justin Barnes to Primed's Board of Directors, establishing institutional governance and operational oversight alongside existing management.
The transaction underscores sustained institutional appetite for mid-market healthcare assets in continental Europe, particularly in subsectors characterized by essential-use consumables and mission-critical sterilization infrastructure. Such assets typically generate stable cash flows underpinned by non-discretionary demand from hospitals and medical device manufacturers, making them defensible investment themes within healthcare-focused private equity strategies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.